Anti-Breast Cancer Potential of SS5020, a Novel Benzopyran Antiestrogen

Treatment with tamoxifen (TAM) increases the risk of developing endometrial cancer in women. The carcinogenic effect is thought to involve initiation and/or promotion resulting from DNA damage induced by TAM as well as its estrogenic action. To minimize this serious side-effect while increasing the...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Suzuki, Naomi, Liu, Xiaoping, Laxmi, Y. R. Santosh, Okamoto, Kanako, Kim, Hyo Jeong, Zhang, Guangxiang, Chen, John J., Okamoto, Yoshinori, Shibutani, Shinya
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3011858/
https://ncbi.nlm.nih.gov/pubmed/20824696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.25659
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires